Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTRK1 | P04629 | 3/20 | 0.50 |
| ▸ | TACR1 | P25103 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3542247 | 0.92 | ALDH1A1 (0.52) | NTRK1TACR1ALDH1A1CHRM3RXFP1 | |
| SCHEMBL29419096 | 0.91 | NTRK1 (0.56) | NTRK1TACR1ALDH1A1ATMCHRM3 | |
| SCHEMBL232104 | 0.91 | NTRK1 (0.56) | NTRK1TACR1ALDH1A1ATMCHRM3 | |
| SCHEMBL302582 | 0.87 | CHRM3 (0.47) | NTRK1ALDH1A1ATMCHRM3IRAK4 | |
| SCHEMBL167627 | 0.86 | CHRM3 (0.47) | NTRK1ALDH1A1ATMCHRM3IRAK4 | |
| SCHEMBL29353394 | 0.86 | CHRM3 (0.47) | NTRK1ALDH1A1ATMCHRM3IRAK4 | |
| SCHEMBL4443686 | 0.86 | LMNA (0.53) | NTRK1TACR1ALDH1A1ATMCHRM3 | |
| SCHEMBL26135329 | 0.86 | NTRK1 (0.52) | NTRK1TACR1ALDH1A1ATMCHRM3 | |
| SCHEMBL1085490 | 0.86 | ALDH1A1 (0.50) | ALDH1A1ATMIRAK4LMNAKDM4E | |
| SCHEMBL10267956 | 0.86 | NTRK1 (0.50) | NTRK1TACR1ALDH1A1ATMCHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090042725-A1 | Fungicidal Mixtures Based on 3,5-Disubstituted N-Biphenyl-Pyrazolcarboxamides | BASF AKTIENGESELLSCHAFT (DE) | 2009-02-12 | — | — | US | claimed |
| US-20090042725-A1 | Fungicidal Mixtures Based on 3,5-Disubstituted N-Biphenyl-Pyrazolcarboxamides | BASF AKTIENGESELLSCHAFT (DE) | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042725-A1 | Fungicidal Mixtures Based on 3,5-Disubstituted N-Biphenyl-Pyrazolcarboxamides | CBR3, CBR1, STS | NTRK1 3679/4885TACR1 670/4885ALDH1A1 433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.